To explore the role of CHST2 in breast cancer progression, we first depleted CHST2 in MDA-MB-231 cells by stably expressing specific targeting shRNAs, subsequently, CHST2 protein levels were examined by Western blot assays (Fig. 2A). This evidence concerns the gene CHST2 and breast carcinoma.